Benzimidazole Derivatives Are Potent against Multiple Life Cycle Stages of Plasmodium falciparum Malaria Parasites
Authors:
Open Access
- 5 March 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 7 (7) , 1945-1955
Abstract
The continued emergence of resistance to front-line antimalarial treatments is of great concern. Therefore, new compounds that potentially have a novel target in various developmental stages of Plasmodium parasites are needed to treat patients and halt the spread of malaria. Here, several benzimidazole derivatives were screened for activity against the symptom-causing intraerythrocytic asexual blood stages and the transmissible gametocyte stages of P. falciparum. Submicromolar activity was obtained for 54 compounds against asexual blood stage parasites with 6 potent at IC50 < 100 nM while not displaying any marked toxicity against mammalian cells. Nanomolar potency was also observed against gametocytes with two compounds active against early stage gametocytes and two compounds active against late-stage gametocytes. The transmission-blocking potential of the latter was confirmed as they could prevent male gamete exflagellation and the lead compound reduced transmission by 72% in an in vivo mosquito feeding model. These compounds therefore have activity against multiple stages of Plasmodium parasites with potential for differential targets.Keywords
Funding Information
- National Research Foundation (110666, 64763, 64767, 84627)
- South African Medical Research Council
This publication has 40 references indexed in Scilit:
- Incorporation of an intramolecular hydrogen bonding motif in the side chain of antimalarial benzimidazolesMedChemComm, 2019
- Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of ActionACS Infectious Diseases, 2018
- Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasitesEuropean Journal of Medicinal Chemistry, 2018
- New developments in anti-malarial target candidate and product profilesMalaria Journal, 2017
- Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and OpportunitiesTrends in Parasitology, 2016
- A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amidesJournal of Medicinal Chemistry, 2015
- Comprehensive Review in Current Developments of Benzimidazole‐Based Medicinal ChemistryChemical Biology & Drug Design, 2014
- Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agentsBioorganic & Medicinal Chemistry, 2011
- A clinical drug library screen identifies astemizole as an antimalarial agentNature Chemical Biology, 2006
- The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged SubstructuresChemical Reviews, 2003